Clinical Trial Update: A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 [Phase 2]

View source ↗

Summary

A multi-center, randomized, double-blind Phase 2 trial comparing placebo, 5 mg, and 10 mg of E2020 (donepezil) in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Limited | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED